Sort
48,018 grants matching “immunotherapy”
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$360,922Malay Haldar · University Of Pennsylvania · R37 · FY2023 · CA
Mechanisms of Adenoid Cystic Carcinoma Development and Tumor Maintenance
$360,916Carlos Caulin · University Of Arizona · R01 · FY2022 · DE
Virus-Host Cell Interactions in AIDS-Associated PML
$360,855Walter J Atwood · Brown University · R01 · FY2014 · NS
Microneedles for allergy immunotherapy
$360,853Harvinder Singh Gill · Texas Tech University · R01 · FY2019 · AI
T32 Urologic Oncology Research Training Grant
$360,828Brett Stewart Carver · Sloan-Kettering Inst Can Research · T32 · FY2025 · CA
Microglia Mediated Inflammation in the Diabetic Retina
$360,811Astrid E Cardona · University Of Texas San Antonio · R01 · FY2022 · EY
Microglia Mediated Inflammation in the Diabetic Retina
$360,810Astrid E Cardona · University Of Texas San Antonio · R01 · FY2021 · EY
T32 Urologic Oncology Research Training Program
$360,808Brett Stewart Carver · Sloan-Kettering Inst Can Research · T32 · FY2022 · CA
CLL clonal evolution and the development of therapy-driven resistance
$360,802Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Immunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling
$360,787Seyed Javad Mirhassani Moghaddam · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Modulation of schistosome development by T cell signals
$360,779Stephen J Davies · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2009 · AI
Modulation of schistosome development by T cell signals
$360,779Stephen J Davies · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2008 · AI
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
$360,766Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers
$360,766Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Immunomodulation Requirements for Treg Immunotherapy for autoimmune diabetes
$360,725Allison Lorayne Bayer · University Of Miami School Of Medicine · R56 · FY2013 · AI
Targeting GPR84 to Overcome Macrophage Mediated Resistance to Immunotherapy
$360,696Gang Xin · Ohio State University · R01 · FY2025 · CA
Targeting GPR84 to Overcome Macrophage Mediated Resistance to Immunotherapy
$360,696Gang Xin · Ohio State University · R01 · FY2023 · CA
Whole Autologous SIV Vaccine Using Dendritic Cells
$360,669University Of Pittsburgh At Pittsburgh · R01 · FY2004 · AI
Epigenetically Engineered Mouse Model for Lung Cancer Therapy
$360,667Lanlan Shen · Baylor College Of Medicine · R01 · FY2025 · CA
Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma
$360,653Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2024 · CA
Establishing the role of MMP9 in amyloid-immunotherapy-induced ARIA
$360,647Donna M. Wilcock · University Of Kentucky · RF1 · FY2022 · NS
HIFU and Immunotherapy Treatment of Metastatic Prostate Cancer
$360,640Narendra T Sanghvi · Focus Surgery, Inc. · R44 · FY2008 · CA
A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis
$360,624Gary Fanger · Rise Therapeutics, Llc · R44 · FY2022 · DK
NEW YORK REGION THALASSEMIA CENTER
$360,600Weill Medical College Of Cornell Univ · U01 · FY2003 · HL
Delineating how nucleic acid sensing in tumorcells regulate anti-tumor immune responses
$360,545Malay Haldar · University Of Pennsylvania · P01 · FY2024 · CA